The objective of the present study was to prepare immediate release tablets (IRTs) of deflazacort by direct compression method. Two types of superdisintegrants i.e. sodium starch glycolate (SSG) and Ac-Di-sol were used in the formulation of tablets. Twelve preliminary batches were prepared by varying the concentration of superdisintegrants. It was found that formulation containing Ac-Di-Sol disintegrated in less time as compared to formulation containing sodium starch glycolate. Values of friability was found to be more in case of formulation containing Ac-DiSol. Attempts were also made to prepare the tablets containing superdisintegrants in combination and these resulted in the formulation with improved values of disintegration time and friability. On the basis of preliminary studies optimization of IRT was done employing 3 2 full factorial design using design expert 7. The optimized batch of IRTs showed friability and disintegration time values of 0.598 and 64.17±3.50 respectively. It was also found that 96.26±1.82% of drug was released within 5 min.
INTRODUCTION
Oral route is the preferred route of administration for administering therapeutic agents. Rate of absorption of drug is controlled by rate of dissolution. Rate of dissolution can be increased by various methods. In present study IRTs were formulated that disintegrate in less time delivering fine suspension of particles of drug with large surface area, resulting in increased rate of dissolution 1 . Deflazacort was chosen as the model drug. Solubility of deflazacort is low thus making its dissolution controlled by disintegration.
Deflazacort is a corticosteroid which is an oxazoline derivative of prednisolone, characterized by a high binding affinity to tissue glucocorticoid receptors and exert antiinflammatory and immunosuppressive effects. Deflazacort significantly inhibits both the proliferation of mononuclear cells derived from human peripheral blood, and the release of inflammatory cytokines by these cells. Thus deflazacort is rapidly effective in symptoms and objective indices of disease activity in rheumatoid arthritis 2 . RA is a chronic disorder in which, the body's own immune system starts to attack body tissues, reasons of which are unknown. This disorder is accompanied with swelling, stiffness and pain. In this disorder the attack is not only directed at the joint but to many other parts of the body. In RA, the joint lining and cartilage gets more damaged which eventually results in erosion of two opposing bones. Based on the studies, it has been reported that deflazacort could be used in treatment of RA. It is as efficacious as prednisolone with less adverse effects as compared to other corticosteroids 3 .
In the formulation of immediate release tablets basic approach is to use superdisintegrants. In the present study two types of superdisintegrants (sodium starch glycolate and Ac-Di-Sol) were used. Concentration of both superdisintegrants was optimized by employing 3 2 full factorial design.
MATERIALS AND METHOD

Materials
Deflazacort and Avicel pH101 was obtained from Oscar Remedies Pvt. Ltd. Haryana, India. Sodium starch glycolate, talc and magnesium stearate was obtained from Nice Chemicals Pvt. Ltd. Kerala, India. Ac-Di-Sol was obtained from Optica Pharmaceuticals, Haryana, India.
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Methods
Preparation of immediate release tablets
Based on composition of deflazacort IRT tablets with deflazacort IRT tablet depicted in table 1 6mg deflazacort and excipients (except the lubricant; magnesium stearate and glidant ; talc) were physically mixed by geometric mixing. Powdered mixture was passed through 60 # sieve and blended properly using a mortar and pestle. The resultant blend was lubricated with the addition of lubricant and glidant and finally compressed into tablets (30 mg) using 3 mm round flat punches. Machine settings were adjusted to get the desired hardness value, which gave an intact tablet. 
Evaluation
The prepared immediate release tablets were evaluated for weight variation and thickness. Using micrometer thickness was determined for twenty tablets 4 . Weight variation of prepared tablets was determined as per USP 5 by taking twenty tablets and comparing average weight with the individual weight of tablets. Hardness of ten tablets 6 from each batch was determined using pfizer hardness tester and Friability of all batches of IRT was determined as per USP 7 using Roche friabilator. Sample of whole tablets corresponding to about 6.5 g was placed in the friabilator and were subjected to 100 revolutions.
The prepared IRTs were subjected to assessment of in-vitro disintegration time using USP-27/NF-22 disintegration test apparatus 8 . Drug content of prepared IRTs were carried out by crushing ten tablets in a glass mortar and transferred quantitatively with methanol in a stoppered conical flask. The flask was placed in a sonicator for 30 min. The mixture was filtered and an aliquot, following suitable dilution, was analyzed at 242 nm using a UV spectrophotometer 9 .
In vitro release study
The dissolution studies of prepared IRTs were carried out using USP type II dissolution test apparatus 10 . The tablets were placed in dissolution vessel containing 900 ml of phosphate buffer pH 6.8 maintained at 37ºC ± 0.5 and stirred at 75 rpm. Samples (6 ml) were collected periodically at different time intervals (1, 2, 4, 6, 8, 10, 15, 20, 25, 30 min) and replaced with fresh dissolution medium. The absorbance was determined spectrophotometrically at 242 nm. Dissolution profiles were constructed as shown in Fig. 1 Concentrations were calculated using calibration curves developed in respective media.
Experimental design
A two factor, three level (3 2 ) FFD was used in the optimization of IRTs of deflazacort. The study design involved the investigation of the effect of independent variables i.e. concentration of Sodium starch glycolate (X1) and concentration of Ac Di Sol (X2) on the dependent variables such as disintegration time, and friability. The levels of the factors study was selected on the basis of preliminary studies. Concentration of sodium starch glycolate (2, 4, 6%) and Ac-Di-Sol (6, 7, 8%) were selected as independent factors X1 and X2 respectively. Combination of these trials is represented in table 2. Nine formulations (Table 3) were prepared according to experimental design. 
Stability studies
To assess the stability of formulation, the optimum IRTs were packed in an amber colored air tight vial and stored at (40 ± 2 °C and 75 ± 5% RH) for a period of 6 months. The tablets were withdrawn after a particular period of time, analyzed for physical appearance, weight, hardness, friability, disintegration time, drug content, and % drug release. At this point, the data was statistically analyzed using ANOVA to test the significance of difference at the level of significance 0.05. Table 5 .
RESULTS AND DISCUSSION
Evaluation of preliminary FDT batches and experimental batches
On the basis of preliminary studies it was found that with increase in concentration of SSG and Ac-Di-Sol tablets disintegrated in less time and value of friability increased. Disintegration time of tablets containing SSG was more as compared to tablets containing Ac-Di-Sol, whereas friability value was more in case of tablets containing Ac-Di-Sol. Thus based on this study both SSG and Ac-Di-Sol were used together for further studies. Drug content of randomly selected ten tablets were determined and it was found that obtained values were within the limits as per USP. Obtained data for experimental batch was found to be between 97.34-103.17%. .358 *** Each value is average of twenty independent determinations; **** Each value is average of ten independent determinations, *****Each value is average of 216 tablets, ****** Each value is average of six independent determinations.
Statistical and response surface analysis of models
Statistical analysis
It was found there was a wide variation in the values of disintegration time and friability with change in concentration of two factors. Table 6 describes the effect of SSG concentrations (2, 4, and 6%) and Ac-Di-Sol concentrations (6, 7 and 8%) on the characteristics of IRT.
Results showed that with increase in concentration of SSG and Ac-Di-Sol disintegration time decreased (Patel et al., 2015) 14 . The formulation (CT1-CT4) showed unaccepted increase in disintegration time (106, 92, 78 and 87 s respectively), that exceeded the limits specified for IRTs, which is less than 75 s (Dobetti 2012) 15 In case of friability it was found that with increase in concentration of SSG and Ac-Di-Sol friability value of IRTs also increased.
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The in vitro drug release data of prepared IRTs is depicted graphically in fig.1 . According to the dissolution profile it was found that the entire batches released drug within 10 min.
Percentage of drug released from all the formulation varied between 95.48-98.86% within 10 min. .798 **** Each value is average of ten independent determinations; *****Each value is average of two hundred sixteen tablets;****** Each value is average of six independent determinations
Optimization
Optimization was done employing a 3 2 FFD. The dependent and independent variables were related using quadratic equations obtained with the Design Expert software (Version 7). For each dependent variable, a summarizing equation was generated as shown in Table 7 . ANOVA was performed to identify insignificant factors. Model selection was based on lower p values than assigned significance level, high F value i.e. 9.68 and 132.42, absence of lack of fit, highest level of adjusted R 2 and predicted R 2 , low standard deviation and lower PRESS value. All values are represented in Table 8 
Response surface analysis
Response surface plots were generated for each response to study the behavior of the system. Response surface plot for friability in Fig. 2 shows that with the increase in the concentration of SSG and Ac-Di-Sol the friability value of the tablet also increases in a linear manner. In case of disintegration time Response surface plot (Fig. 3) shows that with the increase in the concentration of SSG and Ac-Di-Sol the disintegration time decreased in a linear manner. 
Stability studies
Accelerated stability studies on the optimized promising formulation were carried out by storing the tablet at 40 ± 2 °C and 75 ± 5% RH for 3 months. At regular intervals, the formulation was characterized for weight, hardness, disintegration time, friability and drug content. It is found that there was no change in physical appearance, and other tablet characteristics during the study period and at the end of the 3 months. Also, no significant change was shown in the percent drug release. From the statistical analysis, it was found that there was no significant difference between before and after storage (P < 0.05). The similarity factor f2 was calculated to compare the dissolution profiles of optimized formulation before and after storage and it was found to be 84 which is more than 50 indicating similarity between the dissolution profile before and after storage.
Thus, results imply good stability of the formulation on 3-month storage.
CONCLUSION
It can be concluded from the present study that using appropriate concentration of superdisintegrant SSG and AcDi-Sol IRT can be formulated with acceptable values of disintegration time and friability. Addition of superdisintegrating agent resulted in development of a formulation with lesser disintegration time. It was also found that above 90% of drug was released within 5 min. due to quick disintegration of the tablet. Thus the present investigation concluded that it is possible to formulate IRT with acceptable physical characteristics having less disintegration time and could be used to provide immediate relief from the pain and stiffness that occurs in RA.
